The First 75 Days of Novel Coronavirus (SARS-CoV-2) Outbreak: Recent Advances, Prevention, and Treatment
The recent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, previously known as 2019-nCoV) outbreak has engulfed an unprepared world amidst a festive season. The zoonotic SARS-CoV-2, believed to have originated from infected bats, is the seventh member of enveloped RNA coronavirus. Speci...
| Main Authors: | , , , , , , , , , |
|---|---|
| Other Authors: | |
| Format: | Article |
| Published: |
Multidisciplinary Digital Publishing Institute
2020
|
| Online Access: | https://hdl.handle.net/1721.1/124655 |
| _version_ | 1811095743697518592 |
|---|---|
| author | Yan, Yuxin Shin, Woo In Pang, Yoong Xin Meng, Yang Lai, Jianchen You, Chong Zhao, Haitao Lester, Edward Wu, Tao Pang, Cheng Heng |
| author2 | Massachusetts Institute of Technology. Department of Mechanical Engineering |
| author_facet | Massachusetts Institute of Technology. Department of Mechanical Engineering Yan, Yuxin Shin, Woo In Pang, Yoong Xin Meng, Yang Lai, Jianchen You, Chong Zhao, Haitao Lester, Edward Wu, Tao Pang, Cheng Heng |
| author_sort | Yan, Yuxin |
| collection | MIT |
| description | The recent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, previously known as 2019-nCoV) outbreak has engulfed an unprepared world amidst a festive season. The zoonotic SARS-CoV-2, believed to have originated from infected bats, is the seventh member of enveloped RNA coronavirus. Specifically, the overall genome sequence of the SARS-CoV-2 is 96.2% identical to that of bat coronavirus termed BatCoV RaTG13. Although the current mortality rate of 2% is significantly lower than that of SARS (9.6%) and Middle East respiratory syndrome (MERS) (35%), SARS-CoV-2 is highly contagious and transmissible from human to human with an incubation period of up to 24 days. Some statistical studies have shown that, on average, one infected patient may lead to a subsequent 5.7 confirmed cases. Since the first reported case of coronavirus disease 2019 (COVID-19) caused by the SARS-CoV-2 on December 1, 2019, in Wuhan, China, there has been a total of 60,412 confirmed cases with 1370 fatalities reported in 25 different countries as of February 13, 2020. The outbreak has led to severe impacts on social health and the economy at various levels. This paper is a review of the significant, continuous global effort that was made to respond to the outbreak in the first 75 days. Although no vaccines have been discovered yet, a series of containment measures have been implemented by various governments, especially in China, in the effort to prevent further outbreak, whilst various medical treatment approaches have been used to successfully treat infected patients. On the basis of current studies, it would appear that the combined antiviral treatment has shown the highest success rate. This review aims to critically summarize the most recent advances in understanding the coronavirus, as well as the strategies in prevention and treatment. ©2020 |
| first_indexed | 2024-09-23T16:26:35Z |
| format | Article |
| id | mit-1721.1/124655 |
| institution | Massachusetts Institute of Technology |
| last_indexed | 2024-09-23T16:26:35Z |
| publishDate | 2020 |
| publisher | Multidisciplinary Digital Publishing Institute |
| record_format | dspace |
| spelling | mit-1721.1/1246552022-09-29T19:52:14Z The First 75 Days of Novel Coronavirus (SARS-CoV-2) Outbreak: Recent Advances, Prevention, and Treatment Yan, Yuxin Shin, Woo In Pang, Yoong Xin Meng, Yang Lai, Jianchen You, Chong Zhao, Haitao Lester, Edward Wu, Tao Pang, Cheng Heng Massachusetts Institute of Technology. Department of Mechanical Engineering The recent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, previously known as 2019-nCoV) outbreak has engulfed an unprepared world amidst a festive season. The zoonotic SARS-CoV-2, believed to have originated from infected bats, is the seventh member of enveloped RNA coronavirus. Specifically, the overall genome sequence of the SARS-CoV-2 is 96.2% identical to that of bat coronavirus termed BatCoV RaTG13. Although the current mortality rate of 2% is significantly lower than that of SARS (9.6%) and Middle East respiratory syndrome (MERS) (35%), SARS-CoV-2 is highly contagious and transmissible from human to human with an incubation period of up to 24 days. Some statistical studies have shown that, on average, one infected patient may lead to a subsequent 5.7 confirmed cases. Since the first reported case of coronavirus disease 2019 (COVID-19) caused by the SARS-CoV-2 on December 1, 2019, in Wuhan, China, there has been a total of 60,412 confirmed cases with 1370 fatalities reported in 25 different countries as of February 13, 2020. The outbreak has led to severe impacts on social health and the economy at various levels. This paper is a review of the significant, continuous global effort that was made to respond to the outbreak in the first 75 days. Although no vaccines have been discovered yet, a series of containment measures have been implemented by various governments, especially in China, in the effort to prevent further outbreak, whilst various medical treatment approaches have been used to successfully treat infected patients. On the basis of current studies, it would appear that the combined antiviral treatment has shown the highest success rate. This review aims to critically summarize the most recent advances in understanding the coronavirus, as well as the strategies in prevention and treatment. ©2020 2020-04-15T15:43:48Z 2020-04-15T15:43:48Z 2020-03 2020-02 2020-04-15T13:25:38Z Article http://purl.org/eprint/type/JournalArticle 1660-4601 1661-7827 https://hdl.handle.net/1721.1/124655 Yan, Yuxin, et al., "The First 75 Days of Novel Coronavirus (SARS-CoV-2) Outbreak: Recent Advances, Prevention, and Treatment." International Journal of Environmental Research and Public Health 17, 7 (March 2020): no. 2323 doi 10.3390/ijerph17072323 ©2020 Author(s) http://dx.doi.org/10.3390/ijerph17072323 International Journal of Environmental Research and Public Health Creative Commons Attribution https://creativecommons.org/licenses/by/4.0/ application/pdf Multidisciplinary Digital Publishing Institute Multidisciplinary Digital Publishing Institute |
| spellingShingle | Yan, Yuxin Shin, Woo In Pang, Yoong Xin Meng, Yang Lai, Jianchen You, Chong Zhao, Haitao Lester, Edward Wu, Tao Pang, Cheng Heng The First 75 Days of Novel Coronavirus (SARS-CoV-2) Outbreak: Recent Advances, Prevention, and Treatment |
| title | The First 75 Days of Novel Coronavirus (SARS-CoV-2) Outbreak: Recent Advances, Prevention, and Treatment |
| title_full | The First 75 Days of Novel Coronavirus (SARS-CoV-2) Outbreak: Recent Advances, Prevention, and Treatment |
| title_fullStr | The First 75 Days of Novel Coronavirus (SARS-CoV-2) Outbreak: Recent Advances, Prevention, and Treatment |
| title_full_unstemmed | The First 75 Days of Novel Coronavirus (SARS-CoV-2) Outbreak: Recent Advances, Prevention, and Treatment |
| title_short | The First 75 Days of Novel Coronavirus (SARS-CoV-2) Outbreak: Recent Advances, Prevention, and Treatment |
| title_sort | first 75 days of novel coronavirus sars cov 2 outbreak recent advances prevention and treatment |
| url | https://hdl.handle.net/1721.1/124655 |
| work_keys_str_mv | AT yanyuxin thefirst75daysofnovelcoronavirussarscov2outbreakrecentadvancespreventionandtreatment AT shinwooin thefirst75daysofnovelcoronavirussarscov2outbreakrecentadvancespreventionandtreatment AT pangyoongxin thefirst75daysofnovelcoronavirussarscov2outbreakrecentadvancespreventionandtreatment AT mengyang thefirst75daysofnovelcoronavirussarscov2outbreakrecentadvancespreventionandtreatment AT laijianchen thefirst75daysofnovelcoronavirussarscov2outbreakrecentadvancespreventionandtreatment AT youchong thefirst75daysofnovelcoronavirussarscov2outbreakrecentadvancespreventionandtreatment AT zhaohaitao thefirst75daysofnovelcoronavirussarscov2outbreakrecentadvancespreventionandtreatment AT lesteredward thefirst75daysofnovelcoronavirussarscov2outbreakrecentadvancespreventionandtreatment AT wutao thefirst75daysofnovelcoronavirussarscov2outbreakrecentadvancespreventionandtreatment AT pangchengheng thefirst75daysofnovelcoronavirussarscov2outbreakrecentadvancespreventionandtreatment AT yanyuxin first75daysofnovelcoronavirussarscov2outbreakrecentadvancespreventionandtreatment AT shinwooin first75daysofnovelcoronavirussarscov2outbreakrecentadvancespreventionandtreatment AT pangyoongxin first75daysofnovelcoronavirussarscov2outbreakrecentadvancespreventionandtreatment AT mengyang first75daysofnovelcoronavirussarscov2outbreakrecentadvancespreventionandtreatment AT laijianchen first75daysofnovelcoronavirussarscov2outbreakrecentadvancespreventionandtreatment AT youchong first75daysofnovelcoronavirussarscov2outbreakrecentadvancespreventionandtreatment AT zhaohaitao first75daysofnovelcoronavirussarscov2outbreakrecentadvancespreventionandtreatment AT lesteredward first75daysofnovelcoronavirussarscov2outbreakrecentadvancespreventionandtreatment AT wutao first75daysofnovelcoronavirussarscov2outbreakrecentadvancespreventionandtreatment AT pangchengheng first75daysofnovelcoronavirussarscov2outbreakrecentadvancespreventionandtreatment |